News from tris pharma A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 29, 2015, 07:00 ET

Tris Pharma and Pfizer Consumer Healthcare Enter Into Agreement to Commercialize 12-Hour Extended Release Dextromethorphan Cough Syrup under the Robitussin® Brand

Tris Pharma, Inc. ("Tris") today announced that it has entered into a license, supply, and distribution agreement with Pfizer Consumer Healthcare....

May 21, 2015, 07:00 ET

Tris Pharma Announces the FDA Acceptance of NDA for Dyanavel™ XR

Tris Pharma, Inc. ("Tris") announced that U.S. Food and Drug Administration ("FDA") has accepted for review its New Drug Application ("NDA")...

May 01, 2015, 09:27 ET

Vernalis and Tris Pharma receive FDA approval of NDA for Tuzistra™ XR (codeine polistirex and chlorpheniramine polistirex)

Vernalis plc and Tris Pharma Inc. today announce that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for...

Sep 15, 2014, 07:30 ET

FDA accepts Tuzistra™ XR (CCP-01) NDA for full review

Vernalis plc (LSE: VER) and Tris Pharma, Inc. ("Tris") are pleased to announce that the U.S. Food and Drug Administration ("FDA") has...

Aug 27, 2014, 07:30 ET

Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence

Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that it has been...

Jul 22, 2014, 07:00 ET

Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept

 Vernalis plc (LSE: VER) and Tris Pharma, Inc. today announce the achievement of proof-of-concept (POC) for CCP-08, the third programme to...

Jun 26, 2014, 07:45 ET

Tris Pharma Expands R&D Team with addition of Chief Medical Officer and Vice President of Regulatory Affairs

 Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced two key additions to its'...

Apr 01, 2014, 07:45 ET

Tris Pharma Announces Management Changes

 Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced several key management...

Sep 04, 2013, 08:00 ET

Tris Pharma and FSC Laboratories Sign Definitive Commercialization Agreement for Karbinal™ ER (carbinoxamine maleate) Extended-Release Oral Suspension

 Tris Pharma, Inc. and FSC Laboratories, Inc. today announced the signing of a definitive licensing agreement for the commercialization of...

Jul 10, 2013, 08:00 ET

Tris Pharma's Generic Pharmaceuticals Business Launches Dextroamphetamine Sulfate Oral Solution

 Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that its generic...

Jun 20, 2013, 08:00 ET

Tris Pharma Hires President for Generic Pharmaceuticals Business

 Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that it has named...

May 02, 2013, 08:00 ET

Tris Pharma's Ketan Mehta Among Ernst & Young Entrepreneur Of The Year® 2013 Finalists in New Jersey

Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that Ketan Mehta, the...

Apr 03, 2013, 07:30 ET

FDA Approves Tris Pharma's New Drug Application for Karbinal™ ER (carbinoxamine maleate) Extended-release Oral Suspension

 Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S....

Mar 11, 2013, 09:00 ET

First Product in Tris Pharma's Collaboration with Vernalis Achieves Proof-of-Concept, Triggering Milestone Payment to Tris

 Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, announced today receipt of a...

Nov 15, 2012, 09:00 ET

Tris Pharma Appoints New Vice President of Business Development

 Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, announced the appointment of...

Jul 11, 2012, 07:30 ET

Tris Pharma Expands Manufacturing Capacity and Strengthens Supply Chain to Support New and Pending Approvals

 Tris Pharma, a specialty pharmaceutical company with fully integrated commercial manufacturing and drug development operations, announced...

Jun 13, 2012, 12:15 ET

Tris Pharma to Hold Job Fairs - Saturday, June 16 and Saturday, June 23

 Tris Pharma, a technology driven specialty pharmaceutical company announced that it is hosting job fairs for the two consecutive...

May 31, 2012, 07:30 ET

Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension

 Tris Pharma, a technology driven specialty pharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved...

May 10, 2012, 07:30 ET

Tris Pharma Announces Management Additions, Promotion

 Tris Pharma, a technology driven specialty pharmaceutical company, announced today the joining of Ms. Amanda Wohlleber as Vice President of...

Jan 25, 2012, 07:30 ET

Tris Pharma Announces Appointment of Dr. Mahdi Fawzi as Top R&D Executive

Tris Pharma, an emerging specialty pharmaceutical company announced joining of a highly regarded Big Pharma executive Dr. Mahdi Fawzi to its...